4.565USD-6.84%Mkt Cap: 247.84M USDP/E: —Last update: 2026-06-01
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The …
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap247.84M USD
Enterprise Value220.96M USD
Revenue (TTM)79.55M USD
Gross Profit66.67M USD
Net Income (TTM)-38.43M USD
Revenue/Share1.506 USD
Last Price4.565 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees186
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.36
PEG—
EV/EBITDA-8.18
EV/Revenue2.78
P/S3.32
P/B4.07
EPS (TTM)-0.70
EPS (Forward)-0.66
52W Range
3.11024% of range9.236
52W High9.236 USD
52W Low3.110 USD
Profitability
Gross Margin86.17%
Oper. Margin-35.60%
EBITDA Margin-33.96%
Profit Margin-49.67%
ROE-60.10%
ROA-33.33%
Growth
Revenue Growth12.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.69M USD
CapEx (TTM)224.00K USD
FCF Margin-10.78%
FCF Yield-3.46%
Net Debt-43.20M USD
Net Debt/EBITDA1.60
Balance Sheet
Debt/Equity0.64
Current Ratio5.86
Quick Ratio5.26
Book Value/Sh1.195 USD
Cash/Share1.562 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)8.537 USD
Target Range5.150 USD – 12.00 USD
# Analysts4
Ownership
Shares Out.54.41M
Float35.39M
Insiders20.01%
Institutions53.95%
Short Interest
Short Ratio2.5d
Short % Float2.19%
Short % Out.1.59%
Shares Short862.60K
Short (prev mo.)1.07M
Technical
SMA 504.277 (+6.7%)
SMA 2005.236 (-12.8%)
Beta2.38
S&P 52W Chg27.70%
Avg Vol (30d)287.80K
Avg Vol (10d)188.03K
Technical Indicators
RSI (14)53.8
MACD0.1713
MACD Signal0.2022
MACD Hist.-0.0310
BB Upper5.550 USD
BB Middle4.881 USD
BB Lower4.213 USD
BB Width27.39%
ATR (14)0.3252 USD
Vol Ratio (20d)0.36x